Immunologic Response to FluMist vs. Flucelvax
Clinical trial NCT03982069 · COMPLETED
Trial details
- NCT number
- NCT03982069
- Sponsor
- Richard Zimmerman MD
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-20
- Primary completion
- 2020-12-09
- Enrollment
- 465
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.